Turk Ilac Ve Serum Sanayi Anonim Sirketi (IST:TRILC)
0.7100
-0.0200 (-2.74%)
At close: Oct 28, 2026
IST:TRILC Revenue
Turk Ilac Ve Serum Sanayi Anonim Sirketi had revenue of 1.53B TRY in the quarter ending June 30, 2026, with 82.44% growth. This brings the company's total for the last twelve months to 5.59B, up 64.19% year-over-year. In the year 2025, Turk Ilac Ve Serum Sanayi Anonim Sirketi had annual revenue of 4.54B with 35.29% growth. That makes Turk Ilac Ve Serum Sanayi Anonim Sirketi the 21,772nd largest company in the world by revenue and 257th in Turkey.
Revenue (ttm)
5.59B
Revenue Growth
+64.19%
P/S Ratio
0.13
Revenue / Employee
9.88M
Employees
566
Market Cap
736.28M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.54B | 1.18B | 35.29% |
| Dec 31, 2024 | 3.36B | 580.79M | 20.94% |
| Dec 31, 2023 | 2.77B | 1.14B | 69.48% |
| Dec 31, 2022 | 1.64B | 964.30M | 143.37% |
| Dec 31, 2021 | 672.60M | 473.10M | 237.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.